title: Cost-of-illness studies: a guide to critical evaluation.
abstract: Cost-of-illness (COI) studies aim to assess the economic burden of health problems on the population overall, and they are conducted for an ever widening range of health conditions and geographical settings. While they attract much interest from public health advocates and healthcare policy makers, inconsistencies in the way in which they are conducted and a lack of transparency in reporting have made interpretation difficult, and have ostensibly limited their usefulness. Yet there is surprisingly little in the literature to assist the non-expert in critically evaluating these studies. This article aims to provide non-expert readers with a straightforward guide to understanding and evaluating traditional COI studies. The intention is to equip a general audience with an understanding of the most important issues that influence the validity of a COI study, and the ability to recognize the most common limitations in such work.
authors: Discipline of Public Health, School of Population Health and Clinical Practice, The University of Adelaide, South Australia. allison.larg@adelaide.edu.au
authors: Allison
authors: A
authors: Larg
authors: John R
authors: JR
authors: Moss
references: Pharmacoeconomics. 2006;24(7):651-9
references: 16802841
references: Clin Ther. 1998 Jul-Aug;20(4):772-9
references: 9737836
references: Tob Control. 1999 Autumn;8(3):290-300
references: 10599574
references: Pharmacoeconomics. 2008;26(10):815-30
references: 18793030
references: Addiction. 2006 Mar;101(3):315-22
references: 16499503
references: Community Health Stud. 1990;14(4):341-56
references: 2127388
references: Value Health. 2001 Sep-Oct;4(5):370-5
references: 11705127
references: Inj Prev. 2000 Sep;6(3):177-9
references: 11003181
references: J Occup Environ Med. 2010 Mar;52(3):263-8
references: 20190656
references: Am J Public Health. 1999 Aug;89(8):1194-9
references: 10432905
references: PLoS Med. 2008 Feb;5(2):e29
references: 18254654
references: Prev Med. 2007 Apr;44(4):349-55
references: 17289136
references: Soc Sci Med. 2006 Feb;62(4):835-45
references: 16137814
references: Med Care. 2009 Jul;47(7 Suppl 1):S56-63
references: 19536010
references: Pharmacoeconomics. 2008;26(4):269-80
references: 18370563
references: Health Policy. 1989;11(1):57-60
references: 10312927
references: Am J Public Health. 1998 Jan;88(1):15-9
references: 9584027
references: Epidemiol Rev. 1994;16(1):51-64
references: 7925727
references: Pharmacoeconomics. 1996 Nov;10(5):460-6
references: 10172868
references: Pharmacoeconomics. 2004;22(3):149-64
references: 14871163
references: Appl Health Econ Health Policy. 2006;5(2):75-85
references: 16872249
references: Epilepsy Res. 1999 Jan;33(1):39-55
references: 10022365
references: Health Econ. 1996 Sep-Oct;5(5):447-67
references: 8922972
references: Diabetologia. 2010 Feb;53(2):389-90; author reply 391-2
references: 19862498
references: Pharmacoeconomics. 2009;27(5):365-78
references: 19586075
references: J Subst Abuse Treat. 2008 Mar;34(2):224-33
references: 17596904
references: Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429-62
references: 6923138
references: Soz Praventivmed. 2005;50(2):73-4
references: 15900958
references: Community Health Stud. 1986;10(1):31-8
references: 3486091
references: Epidemiology. 1999 Sep;10(5):594-605
references: 10468439
references: Med Care. 2009 Jul;47(7 Suppl 1):S64-9
references: 19536016
references: Int J Epidemiol. 2002 Apr;31(2):422-9
references: 11980807
references: Value Health. 2001 Jul-Aug;4(4):329-34
references: 11705300
references: Am J Hypertens. 2007 Jun;20(6):599-607
references: 17531915
references: Prev Med. 2008 Feb;46(2):127-32
references: 17822752
references: Med Care. 2009 Jul;47(7 Suppl 1):S70-5
references: 19536002
references: BMJ. 2000 May 13;320(7245):1335
references: 10807635
references: Expert Rev Pharmacoecon Outcomes Res. 2003 Aug;3(4):367-9
references: 19807446
references: J Health Econ. 1995 Aug;14(3):387-95
references: 10145141
references: Med Care. 2009 Jul;47(7 Suppl 1):S120-6
references: 19536003
references: Med Care. 2009 Jul;47(7 Suppl 1):S109-14
references: 19536022
references: Am J Public Health. 2004 Sep;94(9):1486-9
references: 15333299
references: Milbank Q. 1988;66(3):444-64
references: 3211088
references: Health Policy. 2008 Oct;88(1):49-61
references: 18407369
references: Dev Health Econ Public Policy. 1996;4:1-245
references: 10158916
references: Obes Res. 2004 Feb;12(2):173-9
references: 14981208
references: Allergy. 2005 Aug;60(8):996-1003
references: 15969679
references: Am J Public Health Nations Health. 1967 Mar;57(3):424-40
references: 6066903
references: Pharmacoeconomics. 2009;27(3):189-98
references: 19354339
references: Am J Public Health. 2002 Jun;92(6):984-9
references: 12036793
references: Addiction. 1999 May;94(5):635-8
references: 10563026
references: Health Serv Res. 2009 Feb;44(1):303-20
references: 19146569
references: Am J Public Health. 1996 Dec;86(12):1723-8
references: 9003128
references: Milbank Q. 1986;64(4):489-547
references: 3102916
references: Med Care. 2009 Jul;47(7 Suppl 1):S51-5
references: 19536019
references: Soc Sci Med. 1999 Feb;48(3):375-91
references: 10077285
references: Health Policy. 2006 Jun;77(1):51-63
references: 16139925
references: J Health Econ. 1983 Aug;2(2):149-59
references: 10263965
references: Am J Epidemiol. 2004 Aug 15;160(4):331-8
references: 15286018
references: Med Care. 2009 Jul;47(7 Suppl 1):S115-9
references: 19536024
references: Health Policy. 1988 Oct;10(2):137-41
references: 10312717
references: Epilepsia. 2002;43 Suppl 4:3-9
references: 12059995
references: Am J Epidemiol. 2005 Oct 1;162(7):618-20; discussion 621-2
references: 16120710
references: Pharmacoeconomics. 1998 Aug;14(2):143-8
references: 10186453
references: Lancet. 1994 Dec 3;344(8936):1519-20
references: 7983947
references: Addiction. 1999 May;94(5):641-4
references: 10563028
references: Health Econ. 2004 Mar;13(3):239-50
references: 14981649
references: Pharmacoeconomics. 2006;24(9):869-90
references: 16942122
references: Health Care Financ Rev. 1985 Fall;7(1):61-80
references: 10311399
references: Spine J. 2008 Jan-Feb;8(1):8-20
references: 18164449
references: Int J Obes (Lond). 2008 Aug;32 Suppl 3:S8-14
references: 18695657
references: Am J Epidemiol. 1988 Dec;128(6):1185-97
references: 3057878
references: Am J Public Health. 1982 Jun;72(6):555-66
references: 6803602
references: Health Policy. 1998 Mar;43(3):243-51
references: 10178574
references: Eur J Health Econ. 2004 Feb;5(1):36-45
references: 15452763
references: Int J Obes (Lond). 2008 Aug;32 Suppl 3:S4-7
references: 18695651
references: Pharmacoeconomics. 1999 Jun;15(6):583-95
references: 10538331
references: J Occup Environ Med. 2010 May;52(5):486-94
references: 20431415
references: Value Health. 2008 Jan-Feb;11(1):13-21
references: 18237356
references: Ann Intern Med. 1982 Jan;96(1):102-9
references: 7053682
references: Diabetes Care. 1998 Aug;21(8):1370-1
references: 9702454
references: Health Policy. 1993 Nov;26(1):29-42
references: 10130844
references: J Health Econ. 1995 Jun;14(2):171-89
references: 10154656
references: Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):463-91
references: 6813766
references: Obesity (Silver Spring). 2007 Dec;15(12):3150-8
references: 18198326
references: Am J Manag Care. 2007 Apr;13(4):211-7
references: 17408341
references: Value Health. 1998 Nov;1(4):251-9
references: 16674550
references: Soc Secur Bull. 1976 Feb;39(2):21-36
references: 828774
references: Med Care. 2009 Jul;47(7 Suppl 1):S104-8
references: 19536020
references: Health Econ. 2002 Jan;11(1):55-70
references: 11788982